Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Custer

Showing results (51-60 of 239) with videos related to

Pageof 24
Sort By:
Transfusion|May 28, 2015
Bimodal distribution of Trypanosoma cruzi antibody levels in blood donors from a highly endemic area of Argentina: what is the significance of low-reactive samples?Mirta Remesar, Ester C Sabino, Ana Del Pozo, et al.
Transfusion|April 11, 2015
Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor?Marjorie Bravo, Beth H Shaz, Hany Kamel, et al.
Transfusion|October 15, 2021
Cost-effectiveness and budget impact of whole blood pathogen reduction in GhanaW Alton Russell, Shirley Owusu-Ofori, Alex Owusu-Ofori, et al.
Transfusion|May 28, 2008
Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture systemLeon L Su, Hany Kamel, Brian Custer, et al.
Plos One|April 26, 2023
Association of ABO and RhD blood groups with the risk of HIV infectionGenevieve Jacobs, Karin Van den Berg, Marion Vermeulen, et al.
Vox Sanguinis|November 29, 2018
Fear of blood, injections and fainting as barriers to blood donation in BrazilMiriane Lucindo Zucoloto, Thelma Gonçalez, Neia Prata Menezes, et al.
Transfusion|December 16, 2010
Donor return after temporary deferralBrian Custer, Karen S Schlumpf, David Wright, et al.
Journal of Medical Economics|November 26, 2011
Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysisHuseyin Naci, Gregory de Lissovoy, Christopher Hollenbeak, et al.
Transfusion|September 29, 2011
Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year periodBrian Custer, Karen Schlumpf, Toby L Simon, et al.
Transfusion Medicine Reviews|September 23, 2023
HIV Pre-Exposure Prophylaxis, Blood Donor Deferral, Occult Infection, and Risk of HIV Transmission by Transfusion: A Fine Balance Between Evidence-Based Donor Selection Criteria and Transfusion SafetyJean-François Leblanc, Brian Custer, Thijs Van de Laar, et al.
Pageof 24

Showing results (51-60 of 239) with videos related to

Sort By:
Pageof 24
Transfusion|May 28, 2015
Bimodal distribution of Trypanosoma cruzi antibody levels in blood donors from a highly endemic area of Argentina: what is the significance of low-reactive samples?Mirta Remesar, Ester C Sabino, Ana Del Pozo, et al.
Transfusion|April 11, 2015
Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor?Marjorie Bravo, Beth H Shaz, Hany Kamel, et al.
Transfusion|October 15, 2021
Cost-effectiveness and budget impact of whole blood pathogen reduction in GhanaW Alton Russell, Shirley Owusu-Ofori, Alex Owusu-Ofori, et al.
Transfusion|May 28, 2008
Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture systemLeon L Su, Hany Kamel, Brian Custer, et al.
Plos One|April 26, 2023
Association of ABO and RhD blood groups with the risk of HIV infectionGenevieve Jacobs, Karin Van den Berg, Marion Vermeulen, et al.
Vox Sanguinis|November 29, 2018
Fear of blood, injections and fainting as barriers to blood donation in BrazilMiriane Lucindo Zucoloto, Thelma Gonçalez, Neia Prata Menezes, et al.
Transfusion|December 16, 2010
Donor return after temporary deferralBrian Custer, Karen S Schlumpf, David Wright, et al.
Journal of Medical Economics|November 26, 2011
Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysisHuseyin Naci, Gregory de Lissovoy, Christopher Hollenbeak, et al.
Transfusion|September 29, 2011
Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year periodBrian Custer, Karen Schlumpf, Toby L Simon, et al.
Transfusion Medicine Reviews|September 23, 2023
HIV Pre-Exposure Prophylaxis, Blood Donor Deferral, Occult Infection, and Risk of HIV Transmission by Transfusion: A Fine Balance Between Evidence-Based Donor Selection Criteria and Transfusion SafetyJean-François Leblanc, Brian Custer, Thijs Van de Laar, et al.
Pageof 24